Turkey Company Roundup: Novartis Tops R&D, Takeda Expanding
This article was originally published in PharmAsia News
Novartis, which has emerged as the top pharmaceutical company by R&D investment in Turkey, is asking for more innovation-supporting policies in the country, while Takeda is expanding and plans to introduce new products in oncology this year. Meanwhile, the AIFD industry association has called for policies to increase Turkey’s capacity for drug exports.
Register for our free email digests: